Viking Therapeutics (VKTX) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to -$0.81.
- Viking Therapeutics' EPS (Basic) fell 26818.18% to -$0.81 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.12, marking a year-over-year decrease of 12795.7%. This contributed to the annual value of -$1.01 for FY2024, which is 1098.9% down from last year.
- Per Viking Therapeutics' latest filing, its EPS (Basic) stood at -$0.81 for Q3 2025, which was down 26818.18% from -$0.58 recorded in Q2 2025.
- Viking Therapeutics' 5-year EPS (Basic) high stood at -$0.16 for Q4 2021, and its period low was -$0.81 during Q3 2025.
- Over the past 5 years, Viking Therapeutics' median EPS (Basic) value was -$0.23 (recorded in 2022), while the average stood at -$0.28.
- Per our database at Business Quant, Viking Therapeutics' EPS (Basic) surged by 1739.13% in 2023 and then crashed by 26818.18% in 2025.
- Quarter analysis of 5 years shows Viking Therapeutics' EPS (Basic) stood at -$0.16 in 2021, then plummeted by 62.5% to -$0.26 in 2022, then increased by 3.85% to -$0.25 in 2023, then fell by 28.0% to -$0.32 in 2024, then crashed by 153.12% to -$0.81 in 2025.
- Its last three reported values are -$0.81 in Q3 2025, -$0.58 for Q2 2025, and -$0.41 during Q1 2025.